Advances In Therapy

Journal Title：Advances In Therapy

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Advances in Therapy 是一份国际性、同行评审、快速出版（2 周内同行评审，接受后 3-4 周出版）期刊，致力于出版高质量的临床（所有阶段）、观察性、真实性围绕所有治疗领域的治疗和干预措施（包括设备）的发现、开发和使用进行世界和健康结果研究。还鼓励与诊断和诊断、药物经济学、公共卫生、流行病学、生活质量以及患者护理、管理和教育相关的研究。

该期刊吸引了广大医疗保健专业人士的兴趣，并发表原创研究、评论、通讯和信件。该杂志由全球读者阅读，并接收来自世界各地的投稿。 Advances in Therapy 将考虑所有科学合理的研究，无论是正面的、证实性的还是负面的数据。无论提交的内容是否与国际和/或特定国家的受众有关，都欢迎提交，这在研究人员试图针对更具体的患者群体时至关重要。这种包容性的方法使期刊能够协助传播所有科学和道德上合理的研究。

Advances In Therapy创刊于2000年，由SPRINGER出版商出版，收稿方向涵盖医学 - 药学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度较慢,6-12周，影响因子指数3.871，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。